EUVIMEDEUVIMED entdecken
Crossref

NB-02 Protects Neurons and Astrocytes from Oligomeric Amyloid-β-Mediated Damage

Morgan R Miller, Lavender Lariviere, Guillaume J Pagnier, Sema Aygar, Natalia Wieckiewicz, Masato Maesako, Brian J Bacskai, Ksenia V Kastanenka

Journal of Alzheimer's Disease · 2024

DOI: 10.3233/jad-231387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Morgan R Miller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, MassGeneral Institute of Neurodegenerative Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown,…. Hauptthemen laut MEDLINE: Astrocytes, Amyloid beta-Peptides, Neurons, Coculture Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disease with limited therapeutic strategies. NB-02 is a novel botanical drug that has shown promise as a protective and therapeutic treatment for AD in an APP/PS1 preclinical mouse model. In this paper, we investigate the underlying mechanisms by which NB-02 provides these therapeutic advantages using in vitro neuron-astrocyte co-cultures. Pretreatment with NB-02 prevented pathological calcium elevations in neurons and astrocytes after application of toxic soluble amyloid-β (Aβ) oligomers. NB-02 also prevented cell death associated with the addition of soluble Aβ oligomers suggesting NB-02 is effective at protecting both neurons and astrocytes from Aβ-mediated damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesAmyloid beta-PeptidesNeuronsCoculture TechniquesNeuroprotective AgentsAnimalsMiceCells, CulturedCalciumPeptide FragmentsHumans

Stichwörter der Autor:innen

Alzheimer’s diseaseDA-9803NB-02amyloidastrocytecalciumneuronoligomertherapy

Substanzen

Amyloid beta-PeptidesNeuroprotective AgentsCalciumPeptide Fragments

Autor:innen und Institutionen

  • Department of Neurology, MassGeneral Institute of Neurodegenerative Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Miller, M. R., Lariviere, L., Pagnier, G. J., Aygar, S., Wieckiewicz, N., Maesako, M., Bacskai, B. J., & Kastanenka, K. V. (2024). NB-02 Protects Neurons and Astrocytes from Oligomeric Amyloid-β-Mediated Damage. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-231387

Vancouver

Miller MR, Lariviere L, Pagnier GJ, Aygar S, Wieckiewicz N, Maesako M, et al. NB-02 Protects Neurons and Astrocytes from Oligomeric Amyloid-β-Mediated Damage. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-231387

BibTeX
@article{Miller2024,
  author = {Miller, Morgan R and Lariviere, Lavender and Pagnier, Guillaume J and Aygar, Sema and Wieckiewicz, Natalia and Maesako, Masato and Bacskai, Brian J and Kastanenka, Ksenia V},
  title = {NB-02 Protects Neurons and Astrocytes from Oligomeric Amyloid-β-Mediated Damage},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  doi = {10.3233/jad-231387}
}
Kostenlos starten →